Effect of fenofibrate on proliferation of SMMC-7721 cells via regulating cell cycle
- 4 February 2021
- journal article
- research article
- Published by SAGE Publications in Human & Experimental Toxicology
- Vol. 40 (7) , 1208-1221
Abstract
Liver cancer is a malignant cancer with great harmfulness. Fenofibrate is a peroxisome proliferation activated receptor (PPARα) agonist widely used in the treatment of dyslipidemia. Previous studies have shown that fenofibrate may promote cell proliferation, but the underlying mechanism has not been fully characterized. The aim of this study was to investigate the role of PPARα agonist fenofibrate in cell proliferation of SMMC-7721 cells compared with that of THLE-2 cells. SMMC-7721 and THLE-2 cells were treated with different concentrations of fenofibrate. Cell proliferation was analyzed by MTT, using flow cytometry for cell cycle analysis, and CyclinD1, Cyclin-dependent kinases2 (CDK2) and Proliferating Cell Nuclear Antigen (PCNA) were analyzed by Western blotting. RT-qPCR method was used to assess CDK2, CyclinD1 and PCNA mRNA levels. The results showed that 10−9–10−4 mol/L fenofibrate could induce cell growth and 10−4, 10−5, 10−6 mol/L fenofibrate could reduce the number of G0/G1 phase cells and increased in the number of cells in S and G2/M phase of cell cycle in SMMC-7721 cells. Furthermore, fenofibrate could significantly increase the expression of cell cycle related protein (CyclinD1, CDK2)and cell proliferation related proteins (PCNA). The use of PPARα inhibitor MT886 inhibited cell cycle progression and promote tumor cell apoptosis. But fenofibrate had no obvious effect on THLE-2 cells. These results revealed the effect of fenofibrate on the cell cycle of liver cancer cells, and provided a reasonable explanation for studying how fenofibrate promotes cell proliferation.Keywords
Funding Information
- Anhui Province Natural Science Foundation (No.1808085MH235)
This publication has 38 references indexed in Scilit:
- High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferationThe Journal of Nutritional Biochemistry, 2013
- Pro-apoptotic effects of tectorigenin on human hepatocellular carcinoma HepG2 cellsWorld Journal of Gastroenterology, 2012
- Optimization of preservation and storage time of sponge tissues to obtain quality mRNA for next‐generation sequencingMolecular Ecology Resources, 2011
- PPARα-Dependent Activation of Cell Cycle Control and DNA Repair Genes in Hepatic Nonparenchymal CellsToxicological Sciences, 2010
- Fenofibrate antagonizes Chk2 activation by inducing Wip1 expression: Implications for cell proliferation and tumorigenesisLife Sciences, 2010
- Effects of Combination Lipid Therapy in Type 2 Diabetes MellitusNew England Journal of Medicine, 2010
- PPARα: Energy Combustion, Hypolipidemia, Inflammation and CancerNuclear Receptor Signaling, 2010
- Hepatocarcinogenic Susceptibility of Fenofibrate and Its Possible Mechanism of Carcinogenicity in a Two-Stage Hepatocarcinogenesis Model of rasH2 MiceToxicologic Pathology, 2008
- Effect of Fenofibrate on Oxidative DNA Damage and on Gene Expression Related to Cell Proliferation and Apoptosis in RatsToxicological Sciences, 2007
- Peroxisome Proliferators: Species Differences in Response of Primary Hepatocyte CulturesAnnals of the New York Academy of Sciences, 1996